SCHEMBL4316291

SCHEMBL4316291

CC(=O)NN1C(=O)NC2(OC(CO)C(O)C(O)C2O)C1=O

nearest known ligand 0.61

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ PYGB P11216 8/20 0.61
▸ PYGL P06737 3/20 0.50
▸ PYGM P11217 2/20 0.50
▸ OGA O60502 1/20 0.33
▸ TOP1 P11387 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4309389 0.78 PYGB (0.71) PYGBPYGLPYGM
SCHEMBL4314468 0.76 PYGB (1.00) PYGBPYGLPYGM
SCHEMBL4313854 0.75 PYGB (1.00) PYGBPYGLPYGM
SCHEMBL29941045 0.67 PYGB (1.00) PYGBPYGLPYGM
SCHEMBL15284881 0.65 PYGB (0.49) PYGBPYGLPYGMOGA
SCHEMBL28379664 0.65 PYGB (0.49) PYGBPYGLPYGMOGA
SCHEMBL1674154 0.65 PYGB (0.49) PYGBPYGLPYGMOGA
SCHEMBL29484208 0.65 PYGB (0.49) PYGBPYGLPYGMOGA
SCHEMBL29406981 0.65 PYGB (0.49) PYGBPYGLPYGMOGA
SCHEMBL4330413 0.65 PYGB (1.00) PYGBPYGLPYGM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 — — US disclosed
US-10877035-B2 Advanced drug development and manufacturing ICAGEN, LLC (US) 2020-12-29 — — US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 — — US disclosed
US-20150309021-A1 Advanced Drug Development and Manufacturing LOS ALAMOS NATIONAL SECURITY, LLC 2015-10-29 — — US disclosed
EP-2511844-B1 X-ray microscope XRPRO SCIENCES INC (US) 2015-08-12 — — EP disclosed
EP-2511844-A2 Advanced drug development and manufacturing Los Alamos National Security, LLC (US) 2012-10-17 — — EP disclosed
EP-2084519-B1 X-RAY FLUORESCENCE ANALYSIS METHOD LOS ALAMOS NAT SECURITY LLC (US) 2012-08-01 — — EP disclosed
EP-2084519-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING Los Alamos National Security, LLC (US) 2009-08-05 — — EP disclosed
WO-2008127291-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING LOS ALAMOS NATIONAL SECURITY, LLC (US) 2008-10-23 — — WO disclosed
US-20080220441-A1 Advanced drug development and manufacturing THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-09-11 — — US disclosed
Send feedback